Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRS | BEKE |
|---|---|---|
| Price | $385.50 | $16.63 |
| Change today | ▼ 0.85% | ▼ 1.34% |
| Market cap | $19.10B | $19.04B |
| Return, 3 months | -36.8% | +10.5% |
| Return, year to date | +22.6% | +7.4% |
| Return, 1 year | +53.6% | -12.3% |
| P/E (TTM) | 36.6 | 26.5 |
| P/B | 8.6 | 1.9 |
| P/E percentile vs own 5y | 56th | 36th |
| Dividend yield | 0.21% | 1.67% |
| Revenue growth (YoY, latest qtr) | +12.6% | -5.7% |
| Net profit growth (YoY) | +45.4% | +100.8% |
| Gross margin | 30.6% | 24.0% |
| Operating margin | 22.5% | 6.1% |
| Net margin | 17.0% | 5.3% |
| Return on equity | 25.7% | 7.0% |
| Analyst target vs. price | +59.2% | +44.8% |
| Analyst buy share | 86% | 100% |
| RSI (14) | 26 | 51 |
| 30-day volatility | 30.8% | 38.4% |
| Max drawdown, 1 year | -37.8% | -28.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
